- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01586351
Rotator Cuff Reconstruction With Xenologous Dermis-patch Augmentation and ACP® - Injection
Arthroscopic Rotator Cuff Reconstruction With Xenologous Dermis-patch Augmentation and ACP® - Injection in Patients Over 60 Years (ACP = Autologous Conditioned Plasma)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The shoulder joint, specially the rotator cuff, is one of the most complicated joints of the human body. If the tendon has to be fixed at the bone during surgery, the weak point in obtaining a successful surgery is the fixation of the tendon at the bone insertion site. Tendon belongs to the bradytrophic tissue conditional on the reduced blood flow, deep mitosis rate and lowered healing potential.
The patients in this study have 60 years or more. The tissue of these patients isn't as good as in young patients. The patch will be used to improve the strength of the tendon at the insertion site and the ingrowth process of the new tissue at this area. Additionally the investigators can boost the healing process with a selective use of PRP (PRP = platelet rich plasma). In this process, the healing site is delivered with an elevated concentration of thrombocytes and also growth factors which are constituent parts of them.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Canton Zürich
-
Zürich, Canton Zürich, Switzerland
- Schulthess Klinik
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Arthroscopic rotator cuff reconstructions of degenerative or traumatic full thickness rotatorcuff tears (supraspinatus should be affected)performed by Dr. Flury
- Age: 60 years or more
- Suture bridge technique
- Women: No longer of childbearing age (at menopause and last menstrual period more than 12 months, prevented surgically Ovaries and/or uterus removed surgically)
- Signed consent form
Exclusion Criteria:
- Partial reconstruction of the rotator cuff (PASTA)
- Open reconstruction
- Tendon transfer (latissimus dorsi or pectoralis major)
- Revision surgery
- Omarthrosis (Level ≥ 2 Samilson & Prieto)
- Systemic arthritis
- Rheumatoid arthritis
- Diabetes (insulin treated)
- Requiring surgery in reconstruction of the subscapularis tendon
- Progressive fat inclusion (fatty infiltration of the rotator cuff musculature goutallier level IV
- Acute or chronic infection
- Pathological bone metabolism
- Insufficient perfusion in the affected arm
- Neuromuscular disease in the affected arm
- Non compliance of the patient
- Disorders which handicap or inhibit the patient to follow the orders of the clinical testers
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Patch and ACP Treatment
Patents who get an patch augmentation and ACP injection following an arthroscopic repair of the rotator cuff.
|
Patch augmentation and 4mL autologous conditioned plasma application under the footprint following an arthroscopic repair of the rotator cuff.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oxford Shoulder Score (Questionnaire)
Time Frame: 3mo
|
The Oxford Shoulder Score used after 3 months is the primary parameter.
The Score tests the ability to participate in the patients' normal life before they got injured.
|
3mo
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
VAS Pain Scoring Tool
Time Frame: 10d
|
Measuring of the pain with a VAS pain scale during 10 days post-operative
|
10d
|
QuickDASH Questionnaire (Short version of Disability of the Arm, Shoulder and Hand Questionnaire)
Time Frame: 3/6/24mo
|
The Disabilities of the Arm, Shoulder and Hand (DASH) Outcome Measure is a 30-item, self-report questionnaire designed to measure physical function and symptoms in patients with any or several musculoskeletal disorders of the upper limb. The QuickDASH is a shortened version of the DASH Outcome Measure. Instead of 30 items, the QuickDASH uses 11 items to measure physical function and symptoms in people with any or multiple musculoskeletal disorders of the upper limb. |
3/6/24mo
|
EQ-5D Questionnaire
Time Frame: 3/6/24 mo
|
EQ-5D is a standardised measure of health status developed by the EuroQol Group in order to provide a simple, generic measure of health for clinical and economic appraisal.Applicable to a wide range of health conditions and treatments, it provides a simple descriptive profile and a single index value for health status that can be used in the clinical and economic evaluation of health care as well as in population health surveys.
|
3/6/24 mo
|
ROM (degrees)
Time Frame: 3/6/24mo
|
Range of motion refers to the distance and direction a joint can move.
|
3/6/24mo
|
Measurement of the abduction strength (Kilograms)
Time Frame: 3/6/24 mo
|
3/6/24 mo
|
|
ASES Score (American Shoulder And Elbow Surgeons Questionnaire)
Time Frame: 3/6/24mo
|
The ASES was developed to measure functional limitations and shoulder pain in people with musculoskeletal pathologies.
Pain score was calculated from a single pain question on a visual analog scale (pain symptoms) and a function score from the sum of 10 questions addressing function using a 4-point ordinal scale (physical function).
Pain and function are weighted equally and the total score ranges from 0 to 100 points, where 0 = worst and 100 = best.
|
3/6/24mo
|
Constant Murley Score (CMS)
Time Frame: 3/6/24 mo
|
The CMS is a 100-point scoring system that is divided into four subscales: pain (15 points), activities of daily living (20 points), range of motion (40 points) and strength (25 points).Pain and activities of daily living are self-reported by the patient using visual analog scales and ordinal categories.
Range of motion is obtained during active painfree elevation in flexion and abduction (using a goniometer), and functional internal and external rotation of the shoulder (using ordinal scale).
Strength testing was performed at 90° of abduction in the scapular plane.
|
3/6/24 mo
|
MRI/X-Ray/Ultrasonic Diagnostics (Objective Evaluation (Descriptive) of the healing process)
Time Frame: 6/24 mo
|
6/24 mo
|
|
Measurement of the external rotation strength (Kilograms)
Time Frame: 3/6/24 mo
|
3/6/24 mo
|
|
Oxford Shoulder Score (Questionnaire)
Time Frame: 6mo/24mo
|
The Oxford Shoulder Score used after 3 months is the primary parameter.
The Score tests the ability to participate in the patients' normal life before they got injured.
|
6mo/24mo
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ACP02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rotator Cuff Tears
-
Xiros LtdNot yet recruitingRotator Cuff Tear | Rotator Cuff Injuries | Rotator Cuff Tears | Rotator Cuff Tears of the Shoulder
-
Gazi UniversityRecruitingMassive Irreparable Rotator Cuff TearsTurkey
-
Parc de Salut MarHospital Clinic of Barcelona; Hospital Universitario Fundación Jiménez Díaz; Hospital... and other collaboratorsRecruitingShoulder Disease | Massive Rotator Cuff TearsSpain
-
The Cleveland ClinicRecruitingRotator Cuff Tears | Rotator Cuff RepairsUnited States
-
Nova Scotia Health AuthorityRecruiting
-
Istituto Ortopedico RizzoliRecruiting
-
La Tour HospitalRecruiting
-
RenJi HospitalNot yet recruiting
-
University Hospitals of Derby and Burton NHS Foundation...Recruiting
-
University Hospitals, LeicesterRecruitingRotator Cuff TearsUnited Kingdom
Clinical Trials on Patch Augmentation and ACP injection
-
Hospital for Special Surgery, New YorkOrthopedic Research and Education FoundationRecruitingPost-traumatic Osteoarthritis | Anterior Cruciate Ligament Injuries | PRPUnited States
-
Dhurakij Pundit UniversityActive, not recruitingEnlarged PoresThailand
-
Visen Pharmaceuticals (Shanghai) Co., Ltd.Ascendis Pharma A/SUnknownEndocrine System Diseases | Pituitary Diseases | Growth Hormone Deficiency | Hormones | Pituitary Disease, AnteriorChina
-
University Hospital, Strasbourg, FranceCompleted
-
University of BernSonnenhof Hospital, BernTerminatedOsteoporosis | Vertebral FractureSwitzerland
-
Humanitas Clinical and Research CenterUnknownPneumothorax | Biopsy WoundItaly
-
Acerta Pharma BVAstraZenecaActive, not recruitingMultiple Myeloma | Non-Hodgkins Lymphoma | B-AllUnited States
-
University of Firenze and Siena, Napoli, ItalyCompletedOral Soft Tissue ConditionsItaly
-
Acerta Pharma BVCompletedHealthy VolunteersUnited States